Mitoxantrone, etoposide, and intermediate-dose cytarabine: an effective and tolerable regimen for the treatment of refractory acute myeloid leukemia.

Source:http://linkedlifedata.com/resource/pubmed/id/2045861

Download in:

View as

General Info

PMID
2045861